To treat relapsed or refractory diffuse massive B-cell lymphoma (not or else specified) and higher-quality B-mobile lymphoma immediately after two or maybe more strains of systemic therapy“The greatest challenge continues to be which the Foods and Drug Administration is simply actually backed up,” said Komac. If she could wave a magic wand, she